Search Results - "JAMA, Yusuf H"

Correlations between Serum Monocyte Chemotactic Protein-1 Levels, Clinical Prognostic Factors, and HER-2/neu Vaccine-Related Immunity in Breast Cancer Patients by DEHQANZADA, Zia A, STORRER, Catherine E, HUEMAN, Matthew T, FOLEY, Rebecca J, HARRIS, Katie A, JAMA, Yusuf H, KAO, Tzu-Cheg, SHRIVER, Craig D, PONNIAH, Sathibalan, PEOPLES, George E

“…Purpose: We studied serum monocyte chemotactic protein-1 (MCP-1) levels in breast cancer patients in relationship to their clinicopathologic variables and…”
Get full text

Circulating regulatory T cells (CD4+ CD25+ FOXP3+ ) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/ neu (AE37) peptide by Gates, Jeremy D, Clifton, Guy T, Benavides, Linda C, Sears, Alan K, Carmichael, Mark G, Hueman, Matthew T, Holmes, Jarrod P, Jama, Yusuf H, Mursal, Mohamed, Zacharia, Athina, Ciano, Kathy, Khoo, Steven, Stojadinovic, Alexander, Ponniah, Sathibalan, Peoples, George E

“…Abstract Regulatory T cells (TReg ), CD4+ CD25+ FOXP3+ , are implicated in suppressing tumor immune responses. We analyzed peripheral blood lymphocytes (PBL)…”
Get full text

Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex® technology by DEHQANZADA, Zia A, STORRER, Catherine E, HUEMAN, Matthew T, FOLEY, Rebecca J, HARRIS, Katie A, JAMA, Yusuf H, SHRIVER, Craig D, PONNIAH, Sathibalan, PEOPLES, George E

“…We used the Luminex assay to compare serum cytokine profiles of breast cancer patients (BCa) to healthy controls, node-positive (NP) patients to node-negative…”
Get full text

Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02 by Amin, Asna, Benavides, Linda C., Holmes, Jarrod P., Gates, Jeremy D., Carmichael, Mark G., Hueman, Matthew T., Mittendorf, Elizabeth A., Storrer, Catherine E., Jama, Yusuf H., Craig, Dianna, Stojadinovic, Alex, Ponniah, Sathibalan, Peoples, George E.

“…Background E75, a HER2/ neu immunogenic peptide, is expressed in breast cancer (BCa). We have performed clinical trials of E75 + GM-CSF vaccine in…”
Get full text

Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine : from US Military Cancer Institute Clinical Trials Group Study 1-01 and 1-02 by AMIN, Asna, BENAVIDES, Linda C, STOJADINOVIC, Alex, PONNIAH, Sathibalan, PEOPLES, George E, HOLMES, Jarrod P, GATES, Jeremy D, CARMICHAEL, Mark G, HUEMAN, Matthew T, MITTENDORF, Elizabeth A, STORRER, Catherine E, JAMA, Yusuf H, CRAIG, Dianna

Get full text